MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Risk of tuberculosis reactivation with tofacitinib (cp-690550)

Maiga M et al. – The goal was to characterize the impact of tofacitinib on LTBI using a mouse model of contained TB. The data indicate that tofacitinib reduces host containment of M.tb. and promotes bacterial replication in the lungs, suggesting TB reactivation. Tofacitinib may carry a significant risk for LTBI reactivation in humans. [more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close